Zantac

Zantac On September 13, 2019, the U.S. Food and Drug Administration (FDA) reported the discovery of the carcinogenic contaminant N-nitrosodimethylamine (NDMA) in Zantac (ranitidine), a common heartburn medication available in both prescription and over-the-counter versions. In April of 2020, the FDA announced that all Zantac brand heartburn drugs, prescription and over-the-counter, should be immediately pulled from the market because of potential NDMA contamination, a chemical linked to cancer. In February 2020, an MDL was established for Zantac in federal court in Florida. Our law firm is serving on the Plaintiffs’ Steering Committee and as head of the Science Committee in the MDL. As of October 2021, more than 1,500 lawsuits were pending in the MDL.

PARMELE LAWYERS

Our attorneys provide free claim reviews, and will be happy to answer your questions and help you to understand your legal options. All Zantac lawsuit services are provided on a contingency basis, meaning there are no legal fees unless we win compensation on your behalf.

Filing a lawsuit is the best means for individual consumers to hold pharmaceutical companies accountable for harmful products. By placing profit motives ahead of consumer safety, the makers of this harmful product have caused undue harm and loss to Americans and their families while reaping the benefits of product sales. Negligent and unscrupulous pharmaceutical companies can, and should, be held accountable for their actions, and injured consumers have a right to seek justice. Filing a lawsuit enables consumers to hold the companies accountable for the safety of their products.

The Parmele Law Firm has a national reputation for its work in family and consumer safety based on an ethic of hard work, reliable advice, and achieving results on behalf of our clients. We will work tirelessly to ensure each of our clients has trustworthy and excellent legal representation. Contact our attorneys to ensure you have an experienced advocate fighting on behalf of your family.